Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-14

FDA Approved: CAPECITABINE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for Capecitabine from Dr. Reddy's Laboratories Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)